- Home
- RVMD vs JEF Comparison
RVMD vs JEF Comparison
Compare RVMD & JEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- JEF
- Stock Information
- Founded
- RVMD 2014
- JEF 1968
- Country
- RVMD United States
- JEF United States
- Employees
- RVMD N/A
- JEF N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- JEF Investment Bankers/Brokers/Service
- Sector
- RVMD Health Care
- JEF Finance
- Exchange
- RVMD Nasdaq
- JEF Nasdaq
- Market Cap
- RVMD 10.2B
- JEF 11.8B
- IPO Year
- RVMD 2020
- JEF N/A
- Fundamental
- Price
- RVMD $56.78
- JEF $76.78
- Analyst Decision
- RVMD Strong Buy
- JEF Buy
- Analyst Count
- RVMD 13
- JEF 3
- Target Price
- RVMD $57.00
- JEF $72.33
- AVG Volume (30 Days)
- RVMD 1.5M
- JEF 1.5M
- Earning Date
- RVMD 11-06-2024
- JEF 01-06-2025
- Dividend Yield
- RVMD N/A
- JEF 1.86%
- EPS Growth
- RVMD N/A
- JEF 68.19
- EPS
- RVMD N/A
- JEF 2.34
- Revenue
- RVMD $742,000.00
- JEF $6,250,606,000.00
- Revenue This Year
- RVMD N/A
- JEF $46.58
- Revenue Next Year
- RVMD $300.00
- JEF $17.01
- P/E Ratio
- RVMD N/A
- JEF $32.03
- Revenue Growth
- RVMD N/A
- JEF 26.50
- 52 Week Low
- RVMD $20.98
- JEF $34.34
- 52 Week High
- RVMD $62.40
- JEF $75.81
- Technical
- Relative Strength Index (RSI)
- RVMD 58.47
- JEF 76.58
- Support Level
- RVMD $53.69
- JEF $72.55
- Resistance Level
- RVMD $62.40
- JEF $75.41
- Average True Range (ATR)
- RVMD 2.21
- JEF 1.69
- MACD
- RVMD -0.43
- JEF 0.41
- Stochastic Oscillator
- RVMD 35.48
- JEF 94.72
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
About JEF Jefferies Financial Group Inc.
Jefferies Financial Group Inc is a diversified financial services company. It has two reportable segments; Investment Banking and Capital Markets which is also the majority revenue generating segment, includes securities, commodities, corporate lending, futures and foreign exchange capital markets activities and its investment banking business, which provides underwriting and financial advisory services to clients across different sectors. The Asset Management reportable business segment provides alternative investment management services to investors in the U.S. and overseas and generates investment income from capital invested in and managed by it or its affiliated asset managers.